Literature DB >> 16024187

Phage therapy reduces Campylobacter jejuni colonization in broilers.

Jaap A Wagenaar1, Marcel A P Van Bergen, Mark A Mueller, Trudy M Wassenaar, Richard M Carlton.   

Abstract

The effect of phage therapy in the control of Campylobacter jejuni colonization in young broilers, either as a preventive or a therapeutic measure, was tested. A prevention group was infected with C. jejuni at day 4 of a 10-day phage treatment. A therapeutic group was phage treated for 6 days, starting 5 days after C. jejuni colonization of the broilers had been established. Treatment was monitored by enumerating Campylobacter colony forming units (CFU) and phage plaque forming units (PFU) from caecal content. Counts were compared with control birds not receiving phage therapy. A clear 3 log decline in C. jejuni counts was initially observed in the therapeutic group, however, after 5 days bacterial counts stabilized at a level 1 log lower than that of the control group. Colonization of C. jejuni in the prevention group was delayed by the treatment and after an initial 2 log reduction, colonization stabilized within a week at levels comparable to the therapeutic group. The CFU and PFU counts displayed opposing highs and lows over time, indicative of alternating shifts in amplification of bacteria and phages. There were no adverse health effects from the phage treatment. Two different phages were combined as therapeutic treatment of Campylobacter positive chickens challenged at the age approaching broiler harvest. This again resulted in a significant decrease in Campylobacter colonization. We conclude that phage treatment is a promising alternative for reducing C. jejuni colonization in broilers.

Entities:  

Mesh:

Year:  2005        PMID: 16024187     DOI: 10.1016/j.vetmic.2005.06.002

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  61 in total

1.  Efficacy of a broad host range lytic bacteriophage against E. coli adhered to urothelium.

Authors:  Sanna Sillankorva; Dulce Oliveira; Alexandra Moura; Mariana Henriques; Alberta Faustino; Ana Nicolau; Joana Azeredo
Journal:  Curr Microbiol       Date:  2010-12-08       Impact factor: 2.188

2.  Stable concentrated emulsions of the 1-monoglyceride of capric acid (monocaprin) with microbicidal activities against the food-borne bacteria Campylobacter jejuni, Salmonella spp., and Escherichia coli.

Authors:  Halldor Thormar; Hilmar Hilmarsson; Gudmundur Bergsson
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

Review 3.  Global Epidemiology of Campylobacter Infection.

Authors:  Nadeem O Kaakoush; Natalia Castaño-Rodríguez; Hazel M Mitchell; Si Ming Man
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

4.  The complete genome sequence of bacteriophage CP21 reveals modular shuffling in Campylobacter group II phages.

Authors:  Jens A Hammerl; Claudia Jäckel; Jochen Reetz; Stefan Hertwig
Journal:  J Virol       Date:  2012-08       Impact factor: 5.103

Review 5.  Phage Therapy in the Era of Synthetic Biology.

Authors:  E Magda Barbu; Kyle C Cady; Bolyn Hubby
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-10-03       Impact factor: 10.005

Review 6.  Bacteriophage biocontrol of foodborne pathogens.

Authors:  Mustafa Kazi; Uday S Annapure
Journal:  J Food Sci Technol       Date:  2015-10-26       Impact factor: 2.701

7.  Bacteriophage-Mediated Dispersal of Campylobacter jejuni Biofilms.

Authors:  Patcharin Siringan; Phillippa L Connerton; Robert J H Payne; Ian F Connerton
Journal:  Appl Environ Microbiol       Date:  2011-03-25       Impact factor: 4.792

Review 8.  Phage Biocontrol of Campylobacter: A One Health Approach.

Authors:  Sophie Kittler; Severin Steffan; Elisa Peh; Madeleine Plötz
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

9.  Evidence for a lineage of virulent bacteriophages that target Campylobacter.

Authors:  Andrew R Timms; Joanna Cambray-Young; Andrew E Scott; Nicola K Petty; Phillippa L Connerton; Louise Clarke; Kathy Seeger; Mike Quail; Nicola Cummings; Duncan J Maskell; Nicholas R Thomson; Ian F Connerton
Journal:  BMC Genomics       Date:  2010-03-30       Impact factor: 3.969

10.  The in vivo efficacy of two administration routes of a phage cocktail to reduce numbers of Campylobacter coli and Campylobacter jejuni in chickens.

Authors:  Carla M Carvalho; Ben W Gannon; Deborah E Halfhide; Silvio B Santos; Christine M Hayes; John M Roe; Joana Azeredo
Journal:  BMC Microbiol       Date:  2010-09-01       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.